PremiumCompany AnnouncementsShenzhen Hepalink to Approve Annual Results and Consider Dividend Shenzhen Hepalink’s Enoparin Gains Approval in Argentina, Boosting Global Expansion Shenzhen Hepalink Receives Approval for Clinical Trial of New Cancer Drug PremiumCompany AnnouncementsShenzhen Hepalink Schedules Board Meeting for Q3 Results Hepalink Announces Strong Mid-Year Financials Shenzhen Hepalink Announces Upcoming Board Meeting